In July, the first direct-to-consumer blood test designed to assess a user’s risk for developing Alzheimer’s disease hit the market.
Tag: Cognitive Testing
ACSM Announces 2020 Paper of the Year Selections
The ACSM Publications Committee established an annual Paper of the Year Award in 2020 to recognize one scientific article from each of ACSM’s five journals. Award-winning articles are selected based on impact, research significance, conceptual design and/or technical innovation.
Subtle Decline in Cognition Predicts Progression to Alzheimer’s Pathology
Researchers at UC San Diego School of Medicine report that abnormal levels of beta-amyloid plaques in brain predict cognitive decline and higher risk of developing Alzheimer’s disease, but also that cognitive performance predicts progression from normal to abnormal levels of beta-amyloid.
Artificial Intelligence Could be ‘Game Changer’ in Detecting, Managing Alzheimer’s Disease
Study Introduces Machine Learning as New Tactic in Assessing Cognitive Brain Health and Patient Care Worldwide, about 44 million people are living with Alzheimer’s disease (AD) or a related form of dementia. Although 82 percent of seniors in the United…